Syndax Pharmaceuticals, Inc.Syndax Pharmaceuticals, Inc.Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

37.500.000.00%
The 14 analysts offering 1 year price forecasts for SNDX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 15 analysts giving stock ratings to SNDX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SNDX EPS for the last quarter is −0.98 USD despite the estimation of −1.07 USD. In the next quarter EPS is expected to reach −0.99 USD. Track more of Syndax Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Syndax Pharmaceuticals, Inc. revenue is expected to reach ‪25.20 M‬ USD. Check out Syndax Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, SNDX price target is 37.50 USD with a max estimate of 51.00 USD and a min estimate of 18.00 USD. Check if this forecast comes true in a year, meanwhile watch Syndax Pharmaceuticals, Inc. stock price chart and keep track of the current situation with SNDX news and stock market news.
We've gathered opinions of 15 analysts rating SNDX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.